Certain online behaviors of docs warrant investigation

Certain online behaviors of docs warrant investigation
There is high consensus among state medical boards regarding the likelihood of probable investigations for certain online behaviors, according to a study published in the Jan. 15 issue of the Annals of Internal Medicine.

(HealthDay)—There is high consensus among state medical boards regarding the likelihood of probable investigations for certain online behaviors, according to a study published in the Jan. 15 issue of the Annals of Internal Medicine.

S. Ryan Greysen, M.D., M.H.S., from the University of California in San Francisco, and colleagues used 10 hypothetical vignettes to gauge the consensus among 48 state medical boards in the United States regarding the likelihood of investigations for violations of online professionalism.

The researchers observed high consensus for the likelihood of investigation for four of the vignettes: providing misleading information about (81 percent); using patient images without consent (79 percent); misrepresenting credentials (77 percent); and contacting patients inappropriately (77 percent). Moderate consensus was found for three vignettes: depicting (73 percent); violating patient confidentiality (65 percent); and using discriminatory speech (60 percent). Low consensus was seen for the remaining three vignettes (using derogatory speech toward patients, showing alcohol use without intoxication, and providing clinical with no confidentiality violation).

"In conclusion, we found a high degree of consensus among state medical boards about the likelihood of investigation for certain online behaviors, whereas consensus in other areas was lower and more dependent on context," the authors write. "Our findings underscore the need for more continuing education of physicians in practice about potential interpretations and consequences of online actions so that their social media presence can be a professional benefit instead of a liability."

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Tausch
not rated yet Jan 15, 2013
@S. Ryan Greysen
Barry Marshall sang that song.

Recognize the face of hypocrisy.